Boyd Biomedical Design Stories
By Boyd Biomedical
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Boyd Biomedical
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 110
Description
This is a show about biomedical innovation.
| Episode | Date |
|---|---|
|
On Point: Open-source product development enabled by AI
|
Dec 04, 2023 |
|
On Point: Investor focus on global health
|
Dec 04, 2023 |
|
On Point: Bending the curve on population health
|
Dec 04, 2023 |
|
On Point: Providing healthcare access to underserved communities
|
Dec 04, 2023 |
|
On Point: The first FDA authorized use of CRISPR
|
Dec 04, 2023 |
|
On Point: The challenges commercializing high-tech, low-cost products
|
Dec 04, 2023 |
|
Bryan Dechairo on the challenges commercializing high-tech, low-cost products
|
Dec 04, 2023 |
|
On Point: Providing access to health information with diagnostic tests
|
Dec 04, 2023 |
|
Bryan Dechairo on providing access to health information with diagnostic tests
|
Dec 04, 2023 |
|
On Point: Raising the stakes in the diagnostics industry
|
Dec 04, 2023 |
|
Julie Garlikov on raising the stakes in the diagnostics industry
|
Dec 04, 2023 |
|
On Point: Improving the user experience in diagnostic testing
|
Dec 04, 2023 |
|
Julie Garlikov on improving the user experience in diagnostic testing
|
Dec 04, 2023 |
|
On Point: The role of life sciences CEO
|
Dec 04, 2023 |
|
Bryan Dechairo on his role as a life sciences CEO
|
Dec 04, 2023 |
|
On Point: Your future healthcare journey
|
Dec 04, 2023 |
|
Bryan Dechairo on your future healthcare journey
|
Dec 04, 2023 |
|
Episode 11: Bryan Dechairo & Julie Garlikov from Sherlock Biosciences
|
Dec 04, 2023 |
|
On Point: Investing in what you know
|
Sep 04, 2023 |
|
On Point: The challenges and benefits of attracting sources of government funding
|
Sep 04, 2023 |
|
On Point: Securing funding to sustain a novel biomedical innovation through the commercial stages
|
Sep 04, 2023 |
|
On Point: The core technology and commercial status of Arsenal's NeoCast product
|
Sep 04, 2023 |
|
On Point: What it means to be a biomaterials platform company
|
Sep 04, 2023 |
|
On Point: The hurdle of reimbursement for a novel breakthrough device
|
Sep 04, 2023 |
|
On Point: Communication and commercialization for a novel biomedical innovation
|
Sep 04, 2023 |
|
On Point: The difference between a founder and an entrepreneur
|
Sep 04, 2023 |
|
On Point: The next evolution of biomedical devices from metal to plastic to biomaterials
|
Sep 04, 2023 |
|
On Point: Addressing biomedical applications that require both biochemical and structural solutions
|
Sep 04, 2023 |
|
On Point: Commercializing biomaterials as medical devices
|
Sep 04, 2023 |
|
Episode 10: Upma Sharma & Carmichael Roberts from Arsenal Medical
|
Sep 04, 2023 |
|
On Point: What success looks like for Paragonix Technologies - no more coolers!
|
Jul 03, 2023 |
|
On Point: Respect for organ donors and their families
|
Jul 03, 2023 |
|
On Point: The cost of transplant procedures
|
Jul 03, 2023 |
|
On Point: Increasing utilization rates of extended criteria donors
|
Jul 03, 2023 |
|
On Point: The necessity to provide a simple solution to a complex procedure
|
Jul 03, 2023 |
|
On Point: The future possibilities for organ transplantation
|
Jul 03, 2023 |
|
On Point: Proving that better organ preservation leads to better outcomes
|
Jul 03, 2023 |
|
On Point: The momentum Paragonix Technologies is experiencing in the market
|
Jul 03, 2023 |
|
On Point: Driving a standard of care change in organ transplantation
|
Jul 03, 2023 |
|
On Point: The origin story of Paragonix Technologies
|
Jul 03, 2023 |
|
Episode 9: Lisa Anderson & Lucas Churchill from Paragonix Technologies
|
Jul 03, 2023 |
|
On Point: How your role changes as a startup CEO
|
Apr 03, 2023 |
|
On Point: How to keep a team balanced while pursuing an ambitious goal
|
Apr 03, 2023 |
|
On Point: The current product development status at Vicarious Surgical
|
Apr 03, 2023 |
|
On Point: The critical technologies enabling surgical robotics
|
Apr 03, 2023 |
|
On Point: Advancing robotic surgery and improving patient care
|
Apr 03, 2023 |
|
On Point: Rethinking surgery with surgical robotics
|
Apr 03, 2023 |
|
On Point: Changing surgical and hospital workflows
|
Apr 03, 2023 |
|
On Point: The impact modern surgical robots will have on the healthcare industry
|
Apr 03, 2023 |
|
On Point: Bringing the world's first purpose-built surgical robot into the market
|
Apr 03, 2023 |
|
On Point: Why the limitations of today's surgical robots have led to low adoption
|
Apr 03, 2023 |
|
Episode 8: Adam Sachs, Sammy Khalifa, & Dr. Barry Greene from Vicarious Surgical
|
Apr 03, 2023 |
|
On Point: Innovation in a market that is inherently disincentivized to change workflows
|
Jan 02, 2023 |
|
On Point: The benefits of proximity of R&D and manufacturing
|
Jan 02, 2023 |
|
On Point: The implications of COVID-19 on vascular access
|
Jan 02, 2023 |
|
On Point: Does having a domestic manufacturing footprint matter to hospitals
|
Jan 02, 2023 |
|
On Point: Are leading hospitals adopting innovative new technologies
|
Jan 02, 2023 |
|
On Point: The impact of value analysis on the adoption of innovation
|
Jan 02, 2023 |
|
On Point: Why innovation in healthcare is so difficult
|
Jan 02, 2023 |
|
On Point: The patient experience when vascular access goes wrong
|
Jan 02, 2023 |
|
Episode 7: Jim Biggins from Access Vascular and & Dr. Gary Ansel from Health Care Insights
|
Jan 02, 2023 |
|
On Point: Workforce challenges for startups when they begin to grow
|
Oct 03, 2022 |
|
On Point: Single points of failure in the life sciences supply chain
|
Oct 03, 2022 |
|
On Point: The state of quality and regulatory affairs for cell and gene therapy manufacturing
|
Oct 03, 2022 |
|
On Point: Addressing the non-availability of starter material in cell and gene therapies
|
Oct 03, 2022 |
|
On Point: The growth trajectory in the cell and gene therapy market
|
Oct 03, 2022 |
|
On Point: Attracting investors to a process technology or manufacturing platform
|
Oct 03, 2022 |
|
On Point: Building patient-centric manufacturing
|
Oct 03, 2022 |
|
On Point: What cell and gene therapy means to advanced manufacturing
|
Oct 03, 2022 |
|
Episode 6: Michael Chiu and John Bonham-Carter from Erbi Biosystems
|
Oct 03, 2022 |
|
On Point: Smart manufacturing and robotics
|
Jul 04, 2022 |
|
On Point: How vertical integration into manufacturing improves quality and innovation
|
Jul 04, 2022 |
|
On Point: Making the long-term strategic investment to manufacture domestically
|
Jul 04, 2022 |
|
On Point: The playbook for a long-term investor strategy
|
Jul 04, 2022 |
|
On Point: The transition in health care from large hospitals to distributed care settings
|
Jul 04, 2022 |
|
On Point: How sustained incremental innovation can beat out incumbents
|
Jul 04, 2022 |
|
On Point: Optimizing the innovation feedback loop
|
Jul 04, 2022 |
|
On Point: The process to pick a winning market strategy
|
Jul 04, 2022 |
|
Episode 5: Leon Amariglio & Shawn Riley from Lexington Medical
|
Jul 04, 2022 |
|
On Point: The case for standardizing curriculum
|
Apr 04, 2022 |
|
On Point: Changing the narrative on advanced manufacturing
|
Apr 04, 2022 |
|
On Point: Women in the life sciences workforce
|
Apr 04, 2022 |
|
On Point: Building a coalition to address workforce challenges in life sciences
|
Apr 04, 2022 |
|
On Point: The strategic vision for the Massachusetts Life Sciences Center
|
Apr 04, 2022 |
|
On Point: The opportunity for America in "manufacturing-led innovation"
|
Apr 04, 2022 |
|
On Point: The 'secret sauce' in Massachusetts' life sciences ecosystem
|
Apr 04, 2022 |
|
On Point: The gaps in the Masschusetts' life sciences ecosystem and the workforce we need to fill them
|
Apr 04, 2022 |
|
Episode 4: Kenn Turner from MLSC & Kendalle Burlin O'Connell from MassBio
|
Apr 04, 2022 |
|
On Point: Accessing and hiring from under-represented populations
|
Feb 07, 2022 |
|
On Point: How to meet the workforce needs of the life sciences industry
|
Feb 07, 2022 |
|
On Point: The relationship between inclusivity and our growing workforce needs
|
Feb 07, 2022 |
|
On Point: Cultivating and growing our life sciences ecosystem
|
Feb 07, 2022 |
|
On Point: Innovation and building a tolerance for failure at the public policy level
|
Feb 07, 2022 |
|
On Point: Making a durable commitment to the life sciences industry
|
Feb 07, 2022 |
|
On Point: Healthcare reform in Massachusetts and its broad coalition of support
|
Feb 07, 2022 |
|
On Point: Disparities in health and lessons learned from the pandemic
|
Feb 07, 2022 |
|
On Point: Trust in public health institutions
|
Feb 07, 2022 |
|
Episode 3: Massachusetts Governor Deval Patrick
|
Feb 07, 2022 |
|
On Point: Inventing therapies that change the course of disease
|
Jan 03, 2022 |
|
On Point: Enabling technologies which accelerate growth in the life sciences
|
Jan 03, 2022 |
|
On Point: Making the life sciences Industry more accessible
|
Jan 03, 2022 |
|
On Point: The growth trajectory of the life sciences industry
|
Jan 03, 2022 |
|
On Point: Changing the drug discovery model in life sciences
|
Jan 03, 2022 |
|
Episode 2: Robert Coughlin & Travis McCready from JLL
|
Jan 03, 2022 |
|
On Point: Entering the golden age of the life sciences industry
|
Nov 09, 2021 |
|
On Point: Start-ups and entrepreneurs - the lifeblood of the life sciences industry
|
Nov 09, 2021 |
|
On Point: The fascination with lifesaving medical technologies
|
Nov 09, 2021 |
|
On Point: The founding vision for MassDevice and the story behind its launch
|
Nov 09, 2021 |
|
Episode 1: Brian Johnson from MassMEDIC
|
Oct 23, 2021 |
|
Trailer
|
Oct 23, 2021 |